Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
CVS Health opens 16 additional new drive-thru test sites in Arizona » 11:02
05/21/20
05/21
11:02
05/21/20
11:02
CVS

CVS Health

$63.72 /

+0.49 (+0.77%)

In an ongoing effort to…

In an ongoing effort to help slow the spread of the virus, CVS Health expanded its COVID-19 testing program by announcing 16 additional test sites at select CVS Pharmacy drive-thru locations across Arizona. The opening of additional test sites on Friday, May 22 add to the 10 locations previously opened on May 15 in Arizona. These new sites will utilize self-swab tests and mark the next phase of the company's nationwide COVID-19 testing strategy, announced April 27. CVS Health expects to have up to 1,000 locations across the country offering this service by the end of May, with the goal of processing up to 1.5 million tests per month, subject to availability of supplies and lab capacity. The 26 test sites in Arizona are part of a total of nearly 350 locations across 14 states including Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, New Jersey, New York, Pennsylvania and Texas.

ShowHide Related Items >><<
CVS CVS Health
$63.72 /

+0.49 (+0.77%)

CVS CVS Health
$63.72 /

+0.49 (+0.77%)

05/14/20
Fly Intel: Top five analyst upgrades
05/14/20 Credit Suisse
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse
05/14/20 Credit Suisse
CVS Health upgraded to Outperform from Neutral at Credit Suisse
03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
CVS CVS Health
$63.72 /

+0.49 (+0.77%)

CVS CVS Health
$63.72 /

+0.49 (+0.77%)

CVS CVS Health
$63.72 /

+0.49 (+0.77%)

CVS CVS Health
$63.72 /

+0.49 (+0.77%)

Over a week ago
Upgrade
Fly Intel: Top five analyst upgrades » 10:04
05/14/20
05/14
10:04
05/14/20
10:04
CVS

CVS Health

$60.56 /

-0.69 (-1.13%)

, AFI

Armstrong Flooring

$2.93 /

+0.62 (+26.84%)

, BBY

Best Buy

$74.73 /

-0.39 (-0.52%)

, WEN

Wendy's

$19.63 /

-0.25 (-1.26%)

, FISV

Fiserv

$97.27 /

-1.62 (-1.64%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CVS Health (CVS) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying a "compelling" valuation, "solid" dividend and defensive business characteristics support more favorable view of the shares. 2. Armstrong Flooring (AFI) upgraded to Buy from Neutral at Nomura Instinet with analyst Michael Wood saying he believes the company's lenders will ease covenants to reflect the post COVID-19 reality, providing "breathing room to survive the downturn and enact the multi-year turnaround plan." 3. Best Buy (BBY) upgraded to Outperform from In Line at Evercore ISI. 4. Wendy's (WEN) upgraded to Outperform from In Line at Evercore ISI. 5. Fiserv (FISV) upgraded to Positive from Neutral at Susquehanna with analyst Brett Huff saying he sees post-merger synergy opportunity, unique high margin software banking business, and a reasonable valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
WEN Wendy's
$19.63 /

-0.25 (-1.26%)

FISV Fiserv
$97.27 /

-1.62 (-1.64%)

CVS CVS Health
$60.56 /

-0.69 (-1.13%)

BBY Best Buy
$74.73 /

-0.39 (-0.52%)

AFI Armstrong Flooring
$2.93 /

+0.62 (+26.84%)

CVS CVS Health
$60.56 /

-0.69 (-1.13%)

05/14/20 Credit Suisse
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse
05/14/20 Credit Suisse
CVS Health upgraded to Outperform from Neutral at Credit Suisse
03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
AFI Armstrong Flooring
$2.93 /

+0.62 (+26.84%)

05/14/20 Nomura Instinet
Nomura upgrades Armstrong Flooring to Buy, sees 120% potential upside
05/14/20 Nomura Instinet
Armstrong Flooring upgraded to Buy from Neutral at Nomura Instinet
03/10/20 Nomura Instinet
Armstrong Flooring price target lowered to $2 from $3 at Nomura Instinet
08/07/19 Nomura Instinet
Armstrong Flooring price target lowered to $8 from $12 at Nomura Instinet
BBY Best Buy
$74.73 /

-0.39 (-0.52%)

05/14/20 Wells Fargo
Best Buy price target raised to $75 from $60 at Wells Fargo
05/14/20 Evercore ISI
Best Buy upgraded to Outperform from In Line at Evercore ISI
05/11/20 Nomura Instinet
Best Buy price target raised to $85 from $70 at Nomura Instinet
05/06/20 Jefferies
Best Buy appointment-only visits may stem sales declines, says Jefferies
WEN Wendy's
$19.63 /

-0.25 (-1.26%)

05/14/20 Evercore ISI
Wendy's upgraded to Outperform from In Line at Evercore ISI
05/13/20 Kalinowski
Wendy's downgraded to Neutral from Buy at Kalinowski
05/11/20 Stephens
Stephens names Texas Roadhouse as a Best Idea
05/07/20 RBC Capital
Wendy's price target raised to $21 from $15 at RBC Capital
FISV Fiserv
$97.27 /

-1.62 (-1.64%)

05/14/20 Susquehanna
Fiserv upgraded to Positive at Susquehanna
05/14/20 Susquehanna
Fiserv upgraded to Positive from Neutral at Susquehanna
05/11/20 Canaccord
Fiserv price target lowered to $135 from $152 at Canaccord
05/08/20 RBC Capital
Fiserv price target raised to $132 from $113 at RBC Capital
WEN Wendy's
$19.63 /

-0.25 (-1.26%)

FISV Fiserv
$97.27 /

-1.62 (-1.64%)

CVS CVS Health
$60.56 /

-0.69 (-1.13%)

BBY Best Buy
$74.73 /

-0.39 (-0.52%)

AFI Armstrong Flooring
$2.93 /

+0.62 (+26.84%)

WEN Wendy's
$19.63 /

-0.25 (-1.26%)

CVS CVS Health
$60.56 /

-0.69 (-1.13%)

BBY Best Buy
$74.73 /

-0.39 (-0.52%)

WEN Wendy's
$19.63 /

-0.25 (-1.26%)

FISV Fiserv
$97.27 /

-1.62 (-1.64%)

CVS CVS Health
$60.56 /

-0.69 (-1.13%)

BBY Best Buy
$74.73 /

-0.39 (-0.52%)

WEN Wendy's
$19.63 /

-0.25 (-1.26%)

FISV Fiserv
$97.27 /

-1.62 (-1.64%)

CVS CVS Health
$60.56 /

-0.69 (-1.13%)

BBY Best Buy
$74.73 /

-0.39 (-0.52%)

On The Fly
Netflix initiation, CVS upgrade among today's top calls on Wall Street » 10:01
05/14/20
05/14
10:01
05/14/20
10:01
NFLX

Netflix

$446.93 /

+8.27 (+1.89%)

, CVS

CVS Health

$60.68 /

-0.57 (-0.93%)

, SDC

SmileDirectClub

$6.87 /

-0.825 (-10.72%)

, SFM

Sprouts Farmers Market

$25.27 /

-0.35 (-1.37%)

, RCII

Rent-A-Center

$22.47 /

-0.02 (-0.09%)

Check out today's top…

Open Full Text

ShowHide Related Items >><<
SFM Sprouts Farmers Market
$25.27 /

-0.35 (-1.37%)

SDC SmileDirectClub
$6.87 /

-0.825 (-10.72%)

RCII Rent-A-Center
$22.47 /

-0.02 (-0.09%)

NFLX Netflix
$446.93 /

+8.27 (+1.89%)

CVS CVS Health
$60.68 /

-0.57 (-0.93%)

NFLX Netflix
$446.93 /

+8.27 (+1.89%)

05/14/20 Jefferies
Jefferies starts Netflix at Buy, lays out three reasons to own
05/14/20 Jefferies
Netflix initiated with a Buy at Jefferies
05/07/20 Stifel
Stifel boosts price target on 'unstoppable juggernaut' Peloton to $50 from $42
04/29/20 Loop Capital
Netflix price target raised to $500 from $490 at Loop Capital
CVS CVS Health
$60.68 /

-0.57 (-0.93%)

05/14/20 Credit Suisse
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse
05/14/20 Credit Suisse
CVS Health upgraded to Outperform from Neutral at Credit Suisse
03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
SDC SmileDirectClub
$6.87 /

-0.825 (-10.72%)

05/14/20 JPMorgan
JPMorgan 'incrementally more positive' on SmileDirectClub after earnings call
05/14/20 BofA
BofA double downgrades SmileDirectClub to Underperform on recovery worries
05/14/20 BofA
SmileDirectClub downgraded to Underperform from Buy at BofA
04/07/20 Goldman Sachs
SmileDirectClub downgraded to Sell from Neutral at Goldman Sachs
SFM Sprouts Farmers Market
$25.27 /

-0.35 (-1.37%)

05/14/20 Oppenheimer
Sprouts Farmers Market downgraded to Perform at Oppenheimer
05/14/20 Oppenheimer
Sprouts Farmers Market downgraded to Perform from Outperform at Oppenheimer
05/06/20 Deutsche Bank
Sprouts Farmers Market price target raised to $33 from $28 at Deutsche Bank
04/21/20
Fly Intel: Top five analyst upgrades
RCII Rent-A-Center
$22.47 /

-0.02 (-0.09%)

05/14/20 Stephens
Stephens upgrades Rent-A-Center with earnings path 'largely unaffected' by virus
05/14/20 Stephens
Rent-A-Center upgraded to Overweight from Equal Weight at Stephens
05/08/20 Loop Capital
Rent-A-Center upgraded to Buy from Hold at Loop Capital
04/07/20 Stephens
Aaron's cut to Equal Weight at Stephens ahead of 'different' type of recession
SFM Sprouts Farmers Market
$25.27 /

-0.35 (-1.37%)

SDC SmileDirectClub
$6.87 /

-0.825 (-10.72%)

RCII Rent-A-Center
$22.47 /

-0.02 (-0.09%)

NFLX Netflix
$446.93 /

+8.27 (+1.89%)

CVS CVS Health
$60.68 /

-0.57 (-0.93%)

SDC SmileDirectClub
$6.87 /

-0.825 (-10.72%)

RCII Rent-A-Center
$22.47 /

-0.02 (-0.09%)

NFLX Netflix
$446.93 /

+8.27 (+1.89%)

CVS CVS Health
$60.68 /

-0.57 (-0.93%)

SDC SmileDirectClub
$6.87 /

-0.825 (-10.72%)

RCII Rent-A-Center
$22.47 /

-0.02 (-0.09%)

NFLX Netflix
$446.93 /

+8.27 (+1.89%)

CVS CVS Health
$60.68 /

-0.57 (-0.93%)

SDC SmileDirectClub
$6.87 /

-0.825 (-10.72%)

NFLX Netflix
$446.93 /

+8.27 (+1.89%)

CVS CVS Health
$60.68 /

-0.57 (-0.93%)

NFLX Netflix
$446.93 /

+8.27 (+1.89%)

Hot Stocks
CVS Health to establish up to 1,000 COVID-19 test sites by end of May » 08:06
05/14/20
05/14
08:06
05/14/20
08:06
CVS

CVS Health

$61.25 /

-2.1 (-3.31%)

Building on the…

Building on the company's comprehensive efforts to help slow the spread of the virus, on Friday, May 15 CVS Health will open more than 50 COVID-19 test sites at select CVS Pharmacy drive-thru locations across Arizona, Connecticut, Florida, Massachusetts and Pennsylvania. The opening of hundreds of additional test sites across the country will be announced over the next two weeks. The new sites will utilize self-swab tests and mark the next phase of the company's COVID-19 testing strategy, announced April 27 at the White House. CVS Health expects to have up to 1,000 locations across the country offering this service by the end of May, with the goal of processing up to 1.5M tests per month, subject to availability of supplies and lab capacity. The company currently operates large-scale rapid test sites in coordination with five states, which can process a total of nearly 30,000 tests per week. Testing will not take place inside any retail locations, and CVS Pharmacy, HealthHUB and MinuteClinic will continue to serve customers and patients.

ShowHide Related Items >><<
CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

05/14/20 Credit Suisse
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse
05/14/20 Credit Suisse
CVS Health upgraded to Outperform from Neutral at Credit Suisse
03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

Upgrade
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse » 06:05
05/14/20
05/14
06:05
05/14/20
06:05
CVS

CVS Health

$61.25 /

-2.1 (-3.31%)

Credit Suisse analyst…

Credit Suisse analyst A.J. Rice upgraded CVS Health to Outperform from Neutral with an unchanged price target of $75. A "compelling" valuation, "solid" dividend and defensive business characteristics support more favorable view of the shares, Rice tells investors in a research note. Deferral of elected procedures should benefit CVS Health's health care benefits segment while its "strong" government exposure provides support in in an economic downturn, adds the analyst.

ShowHide Related Items >><<
CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

05/14/20 Credit Suisse
CVS Health upgraded to Outperform from Neutral at Credit Suisse
03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
03/12/20 Canaccord
Livongo Health weakness a buying opportunity, says Canaccord
CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

Upgrade
CVS Health upgraded to Outperform from Neutral at Credit Suisse » 05:38
05/14/20
05/14
05:38
05/14/20
05:38
CVS

CVS Health

$61.25 /

-2.1 (-3.31%)

Credit Suisse analyst AJ…

Credit Suisse analyst AJ Rice upgraded CVS Health to Outperform from Neutral with a $75 price target.

ShowHide Related Items >><<
CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
03/12/20 Canaccord
Livongo Health weakness a buying opportunity, says Canaccord
02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate
CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

CVS CVS Health
$61.25 /

-2.1 (-3.31%)

Hot Stocks
CVS unit pays $15.3M civil penalty for improper opioid dispensing » 13:52
05/13/20
05/13
13:52
05/13/20
13:52
CVS

CVS Health

$61.13 /

-2.22 (-3.50%)

United States Attorney…

United States Attorney for Colorado Jason Dunn announced that Omnicare, a subsidiary of CVS Health, has agreed to pay the United States a $15.3M civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed without a valid prescription. The United States alleged that Omnicare violated the federal Controlled Substances Act in its handling of emergency prescriptions, its controls over the emergency kits, and its processing of written prescriptions. Reference Link

ShowHide Related Items >><<
CVS CVS Health
$61.13 /

-2.22 (-3.50%)

CVS CVS Health
$61.13 /

-2.22 (-3.50%)

03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
03/12/20 Canaccord
Livongo Health weakness a buying opportunity, says Canaccord
02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate
CVS CVS Health
$61.13 /

-2.22 (-3.50%)

CVS CVS Health
$61.13 /

-2.22 (-3.50%)

CVS CVS Health
$61.13 /

-2.22 (-3.50%)

CVS CVS Health
$61.13 /

-2.22 (-3.50%)

Periodicals
Walgreens reviewing global advertising account, AdWeek reports » 15:13
05/12/20
05/12
15:13
05/12/20
15:13
CVS

CVS Health

$63.71 /

-0.12 (-0.19%)

, IPG

Interpublic Group

$16.42 /

-0.28 (-1.68%)

, WPP

WPP

$36.14 /

-0.42 (-1.15%)

, WBA

Walgreens Boots Alliance

$41.21 /

-0.5 (-1.20%)

Walgreens (WBA) is…

Walgreens (WBA) is reviewing its global advertising account, AdWeek's Erik Oster reports. The global creative and media review includes all of its brands and follows the conclusion of the company's three-year contract with WPP (WPP), the author notes, adding that the latter is defending in the review process, which is being handled by MediaLink, according to sources. Discussions around the review dated back to before the impact of the coronavirus pandemic, and other major holding companies are also participating in the process, with the exception of IPG (IPG), which works with competitor CVS (CVS), according to a source familiar with the matter. Reference Link

ShowHide Related Items >><<
WPP WPP
$36.14 /

-0.42 (-1.15%)

WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
03/12/20 Canaccord
Livongo Health weakness a buying opportunity, says Canaccord
02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate
IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

04/15/20 Citi
Interpublic Group price target lowered to $19 from $28 at Citi
03/25/20 JPMorgan
Interpublic Group price target lowered to $24 from $29 at JPMorgan
09/23/19 Wells Fargo
Interpublic Group initiated with a Market Perform at Wells Fargo
07/10/19 BofA
Interpublic Group upgraded to Neutral from Underperform at BofA/Merrill
WPP WPP
$36.14 /

-0.42 (-1.15%)

04/30/20 JPMorgan
WPP price target raised to 750 GBp from 630 GBp at JPMorgan
04/16/20 Kepler Cheuvreux
WPP upgraded to Buy from Hold at Kepler Cheuvreux
03/26/20 Kepler Cheuvreux
WPP upgraded to Buy from Hold at Kepler Cheuvreux
01/20/20 Goldman Sachs
WPP downgraded to Neutral from Buy at Goldman Sachs
WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

05/05/20 Guggenheim
Walgreens shares likely react positively to Amerisource report, says Guggenheim
04/06/20
Fly Intel: Top five analyst upgrades
04/06/20 UBS
Walgreens Boots Alliance upgraded to Neutral from Sell at UBS
04/03/20 SunTrust
Walgreens Boots Alliance price target lowered to $42 from $58 at SunTrust
WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

WBA Walgreens Boots Alliance
$41.21 /

-0.5 (-1.20%)

IPG Interpublic Group
$16.42 /

-0.28 (-1.68%)

CVS CVS Health
$63.71 /

-0.12 (-0.19%)

Conference/Events
CVS Health participates in a conference call with JPMorgan » 09:25
05/11/20
05/11
09:25
05/11/20
09:25
CVS

CVS Health

$63.10 /

+1.65 (+2.69%)

Healthcare Technology…

Healthcare Technology Analyst Gill holds a conference call with CEO Merlo on May 11 at 10 am hosted by JPMorgan.

ShowHide Related Items >><<
CVS CVS Health
$63.10 /

+1.65 (+2.69%)

03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
03/12/20 Canaccord
Livongo Health weakness a buying opportunity, says Canaccord
02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate
Conference/Events
CVS Health participates in a conference call with JPMorgan » 04:55
05/11/20
05/11
04:55
05/11/20
04:55
CVS

CVS Health

$63.10 /

+1.65 (+2.69%)

Healthcare Technology…

Healthcare Technology Analyst Gill holds a conference call with CEO Merlo on May 11 at 10 am hosted by JPMorgan.

ShowHide Related Items >><<
CVS CVS Health
$63.10 /

+1.65 (+2.69%)

03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
03/24/20 Cowen
CVS Health outperformance should continue post-virus, says Cowen
03/12/20 Canaccord
Livongo Health weakness a buying opportunity, says Canaccord
02/20/20 Stephens
Stephens watching near-term MCO stock reactions after Bloomberg's 'rough' debate

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.